Latest filing published 21 Mar 2023 for Staar Surgical Co, €53k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Keith Holliday (senior executive) discloses dealings in Staar Surgical Co to SEC (Form 4). In total, 8 filings cover trades dated from 10 May 2021 to 20 March 2023.
Every open-market trade on record is a sale: 3 sales worth €1.4M. Besides market trades, the filings include 3 share grants and 2 option exercises. 2023 to date brings no purchases and 1 sale.
The latest filing, published on 21 March 2023, reports a share grant of €53k in Staar Surgical Co. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations